BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35358902)

  • 41. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation].
    Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic variation of TNF-α and IL-10, IL-12, IL-17 genes and association with torque teno virus infection post hematopoietic stem cell transplantation.
    Ramzi M; Arandi N; Zarei T; Saadi MI; Yaghobi R; Moghadam M; Geramizadeh B
    Acta Virol; 2019; 63(2):186-194. PubMed ID: 31230447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.
    Sobiak J; Kazimierczak U; Kowalczyk DW; Chrzanowska M; Styczyński J; Wysocki M; Szpecht D; Wachowiak J
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):385-95. PubMed ID: 26040247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients].
    Jin Z; Xu C; Duan W; Yang J; Tian P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):947-952. PubMed ID: 28712403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
    Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
    Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
    Zheng C; Zhu X; Tang B; Yao W; Song K; Tong J; Geng L; Liu H; Sun Z
    Ann Hematol; 2015 Mar; 94(3):473-80. PubMed ID: 25217231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance.
    Minguela A; Torío A; Marín L; Muro M; Villar LM; Díaz J; Ramírez P; Parrilla P; García-Alonso AM; Alvarez-López MR
    Hum Immunol; 1999 Jun; 60(6):500-9. PubMed ID: 10408799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
    Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
    Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation.
    Min CK; Lee WY; Min DJ; Lee DG; Kim YJ; Park YH; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2001 Nov; 28(10):935-40. PubMed ID: 11753547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation.
    Wang XS; Shi Q; Williams LA; Cleeland CS; Mobley GM; Reuben JM; Lee BN; Giralt SA
    Cancer; 2008 Oct; 113(8):2102-9. PubMed ID: 18792065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia.
    Pearce KF; Lee SJ; Haagenson M; Petersdorf EW; Norden J; Collin MP; Klein JP; Spellman SR; Lowerson SA; Davies S; Dickinson AM
    Haematologica; 2012 Jul; 97(7):1014-9. PubMed ID: 22271889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
    Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
    Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.
    Fainardi E; Bortolotti D; Castellazzi M; Casetta I; Bellini T; Rizzo R
    Hum Immunol; 2020 Apr; 81(4):156-161. PubMed ID: 31735441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Samuel S; Kapelushnik J; Brautbar C; Or R
    Blood; 1996 Mar; 87(6):2195-204. PubMed ID: 8630379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.
    Sipak-Szmigiel O; Włodarski P; Ronin-Walknowska E; Niedzielski A; Karakiewicz B; Słuczanowska-Głąbowska S; Laszczyńska M; Malinowski W
    J Ovarian Res; 2017 Apr; 10(1):25. PubMed ID: 28376925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correlation between serum levels of IL-18 and acute graft versus host disease in patients after allogeneic hematopoietic stem cell transplantation].
    Liu J; Zhang XG; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):553-7. PubMed ID: 17605864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A
    J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune regulation of hydrogen sulfide in children with acute lymphoblastic leukemia.
    Du S; Jia Y; Tang H; Sun Y; Wu W; Sun L; Du J; Geng B; Tang C; Jin H
    Chin Med J (Engl); 2014; 127(21):3695-9. PubMed ID: 25382321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical Summarization of Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: A Report of 100 Cases].
    Huang QX; Tu SF; Huang R; Huang YX; Deng L; Wu BY; Song CY; Li YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):556-61. PubMed ID: 27151029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.